Skip to main content
OpenTrials
Completed

NCT Number: NCT03027908

A Study to Measure the Effect of Two Fluoride Toothpastes on Gingival Health Over a Six Month Period

This study is a double-blind, randomised, parallel group efficacy study. A minimum of 240 healthy female and male participants aged over 18 years will participate. The participants will be randomised into two groups. Participants will be randomly assigned to the test groups according the allocation table prepared by the Statistician.

Participants will be enrolled on to the study according to the inclusion/exclusion criteria. After enrollment participants will have their teeth cleaned using a professional prophylaxis polish by the study hygienist. The participants will then be provided with a standard cosmetic silica fluoride toothpaste and a toothbrush to use at home, twice a day for up to four weeks. After this time, they will return to the test site and have the baseline dental assessments. Participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments will be conducted after 13 and 26 weeks of product use at the study site.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gingival Diseases Mouth Diseases Periodontal Diseases Stomatognathic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be willing and physically able to carry out all study procedures.
  • Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form.
  • Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant
  • Have a mean Modified Gingival Index (MGI) score of between 2.00 and 2.75 at screening.
  • Not have had a scale and prophylaxis in the month prior to enrolment or have one scheduled prior to the end of the study.
  • Be willing to use only the test products for 6 months

Exclusion criteria

  • Current participation in any other cosmetic trials, any dental clinical trials or clinical trials.
  • Pregnant or breast feeding mothers.
  • Medical condition and/or regular use of any medication which might affect the outcome of the study, as determined by the study dentist, principally a course of anti-inflammatory, antimicrobial or statin drugs
  • Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, will affect either the scientific validity of the study or if the participant was to participate in the study would affect their wellbeing.
  • Any participant who, in the judgement of the investigator, should not participate in the study.
  • Full or partial dentures wearers.
  • Current orthodontic treatment.
  • Have oral piercings.
  • Smokers or those who have a recent smoking history, including e-cigarettes.
  • Taking dietary supplements (e.g. multivitamins; antioxidants; fish oils).
  • Any subject with a single MGI score of 4 in the any area of the mouth at any time point will be excluded.
  • A subject will be excluded from the study if they have a MGI mouth mean of greater than 2.75 at screening
  • Any subject with a single MGI score of 3 at Baseline
  • Use of non study oral care products, e.g. dental floss, chewing gum, mouth rinses during the pre treatment and test phases of the study.
  • The subject is an employee of Unilever or a member of the study team.
  • Taking a course of antimicrobial or anti-inflammatory drugs within 4 weeks of screening
  • Those taking anti-histamine or anti-inflammatory medication in the 24 hours prior to the dental assessments
  • Diabetics
  • Vegetarians and Vegans

Treatment and study plan

Fluoride Toothpaste 1

Other

Toothpaste containing 1450 ppm F as Sodium Fluoride

Other names: A1

Fluoride Toothpaste 2

Other

Toothpaste containing 1450 ppm F as Sodium Fluoride

Other names: A2

Primary outcomes

  1. Change in gingival condition as measured by the Modified Lobene Gingival Index

    Time frame: 13 weeks

  2. Change in gingival condition as measured by the Saxton van der Ouderaa bleeding index

    Time frame: 13 weeks

  3. Change in plaque levels as measure by the Quigley and Hein Plaque index

    Time frame: 13 weeks

Secondary outcomes

  1. change in gingival condition as measured by the Modified Lobene Gingival Index

    Time frame: 26 weeks

  2. change in gingival condition as measured by the Saxton van der Ouderaa bleeding index

    Time frame: 26 weeks

  3. Change in plaque levels as measured by the Quigley and Hein plaque index

    Time frame: 26 weeks

Sponsors and collaborators

Lead sponsor

Unilever R&D

Industry

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 23, 2017
Registry last updated
Jun 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.